Improving the diagnosis and classification of Ph-negative myeloproliferative neoplasms through deep phenotyping
Sirinukunwattana K. et al, (2019), bioRxiv
Transcriptomic profiling of the myeloma bone-lining niche reveals BMP signalling inhibition to improve bone disease
GOODING S. et al, (2019), Nature Communications
Germline selection shapes human mitochondrial DNA diversity.
Wei W. et al, (2019), Science (New York, N.Y.), 364
Single-cell approaches reveal novel cellular pathways for megakaryocyte and erythroid differentiation.
Psaila B. and Mead AJ., (2019), Blood, 133, 1427 - 1435
Single-cell assessment of transcriptome alterations induced by Scriptaid in early differentiated human haematopoietic progenitors during ex vivo expansion
ROBERTS IRENE. et al, (2019), Scientific Reports
Unravelling Intratumoral Heterogeneity through High-Sensitivity Single-Cell Mutational Analysis and Parallel RNA Sequencing.
Rodriguez-Meira A. et al, (2019), Mol Cell, 73, 1292 - 1305.e8
UK results from the myeloproliferative neoplasms (MPN) landmark survey on the symptom, emotional and economic burden of MPN.
Harrison C. et al, (2019), British journal of haematology
A physician survey on the application of the British Society for Haematology guidelines for the diagnosis and management of myelofibrosis in the UK
Harrison C. et al, (2019), BRITISH JOURNAL OF HAEMATOLOGY, 185, 66 - 67
A Retrospective Real World Evidence Study To Review The Current Treatment Pathways for Myelofibrosis From Across The United Kingdom (The REALISM UK Study)
Mead A. et al, (2019), BRITISH JOURNAL OF HAEMATOLOGY, 185, 8 - 9
The UK Myeloproliferative Neoplasm Registry for Myelofibrosis (UK-MPN-MF registry)
Butt NM. et al, (2019), BRITISH JOURNAL OF HAEMATOLOGY, 185, 54 - 55
Whole genome sequencing for the investigation of rare anaemias: Challenges and real-world outcomes
Brierley C. et al, (2019), BRITISH JOURNAL OF HAEMATOLOGY, 185, 115 - 116
Ruxolitinib Therapy Followed by Reduced-Intensity Conditioning for Hematopoietic Cell Transplantation for Myelofibrosis: Myeloproliferative Disorders Research Consortium 114 Study.
Gupta V. et al, (2019), Biol Blood Marrow Transplant, 25, 256 - 264
A guideline for the management of specific situations in polycythaemia vera and secondary erythrocytosis: A British Society for Haematology Guideline.
McMullin MFF. et al, (2019), British journal of haematology, 184, 161 - 175
Heterogeneity in myeloproliferative neoplasms: Causes and consequences.
O'Sullivan J. and Mead AJ., (2019), Adv Biol Regul, 71, 55 - 68
From Pioneer to Repressor: Bimodal foxd3 Activity Dynamically Remodels Neural Crest Regulatory Landscape In Vivo.
Lukoseviciute M. et al, (2018), Dev Cell, 47, 608 - 628.e6
From pioneer to repressor: Bimodal foxd3 activity dynamically remodels neural crest regulatory landscape in vivo
Lukoseviciute M. et al, (2018), Developmental Cell
Longitudinal Mutational Analysis in Hydroxycarbamide-Resistant/Intolerant Essential Thrombocythemia Treated on the Majic-ET Study
O'Sullivan J. et al, (2018), BLOOD, 132
Niche Heterogeneity Impacts Evolution of Myeloproliferative Neoplasms Driven By the Same Oncogenic Pathway
Korn C. et al, (2018), BLOOD, 132
Spliceosome Mutations Are Common in MPN-Associated Myelofibrosis with RBC-Transfusion-Dependence and Correlate with Response to Pomalidomide
Chowdhury O. et al, (2018), BLOOD, 132
A guideline for the diagnosis and management of polycythaemia vera
MEAD AJ. et al, (2018), British Journal of Haematology